查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1159300

妇产科体检的全球市场(2022年～2028年)

Women's Health Diagnostics Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

全球妇产科体检的市场规模在预测期间内预计将以7.5％大幅年复合成长率成长。推动市场成长的主要因素有主要企业的投资增加等。

本报告提供全球妇产科体检市场调查，提供市场概要，市场趋势的分析，各类型·各用途·各终端用户·各地区的分析，竞争情形，再加上主要企业的简介等全面性资讯。

目录

第1章 报告概要

第2章 市场概要与见解

  • 调查范围
  • 分析师的见解与目前市场趋势

第3章 竞争情形

  • F. Hoffmann-La Roche Ltd
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • General Electric Co.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • Hologic, Inc.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • PerkinElmer Inc.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • Siemens Medical Solutions USA, Inc.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • 主要策略分析
  • COVID-19对主要企业的影响

第4章 市场区隔

  • 全球妇产科体检市场:各类型
    • 诊断设备
    • 诊断检验
  • 全球妇产科体检市场:各用途
    • 乳癌检验
    • 子宫颈抹片(PAP)(PAP)·HPV检验
    • 传染病检查
    • 骨质疏鬆症检验
    • 妊娠·不孕检验
    • 性传染病检查
    • 其他
  • 全球妇产科体检市场:各终端用户
    • 居家医疗
    • 医院·诊疗所
    • 诊断·影像中心

第5章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 其他地区

第6章 企业简介

  • Abbott Laboratories
  • Becton, Dickinson and Co
  • BIOMERIEUX, INC.
  • Bio-Rad Laboratories, Inc.
  • BOSTON IMAGING
  • Canon Medical Systems Corp.
  • Carestream Health, Inc.
  • Cook Group Inc
  • DiaSorin S.p.A
  • Grifols, S.A.
  • Konica Minolta Healthcare Americas, Inc.
  • Laboratory Corp.
  • Myriad Genetics, Inc.
  • MedGyn Products, Inc.
  • Ortho Clinical Diagnostics
  • Philips International B.V.,
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • Ziehm Imaging GmbH
Product Code: OMR2026422

Global Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Diagnostic Devices(Biopsy Devices, and Tests) by Application (Breast Cancer Testing, PAP Smear (PAP) and HPV Test, Infectious Disease Testing, Osteoporosis Testing, Pregnancy, and Fertility Testing, Sexually Transmitted Disease Testing, and Others) and by End User (Home Care, Hospitals & Clinics, and Diagnostic and Imaging Centers) Forecast Period (2022-2028)

The global women's health diagnostics market is anticipated to grow at a substantial CAGR of 7.5% during the forecast period. An increasing investments initiatives by key players are accepted to contribute to the growth of the market. Moreover, such initiatives are greater in the availability of more comfortable and convenient option that leads to great adoption of medical devices. For instance, in March 2022, Willow launched a new cord-free smart breast pump. It is priced at $329 and will be available with insurance plans that offer breast pumps for free or at a reduced cost, many will only cover the cost of a manual breast pump.

The global women's health diagnostics market is segmented based on diagnostic devices, application, and end-user. Based on diagnostic devices, the market is segmented into biopsy devices and tests. Based on the application, the market is sub-classified into cancer testing, PAP smear (PAP) and HPV test, infectious disease testing, osteoporosis testing, pregnancy, and fertility testing, sexually transmitted disease testing, and others. Based on the end-user, the market is sub-divided into home care, hospitals & clinics, and diagnostic and imaging centers. Among the end-user segment, the hospitals & clinics segment is dominating owing to the high number of patients visits and rising diagnostic procedures related to women health.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The regional growth is attributed to the presence of better healthcare infrastructure, and increased women's major health issues which is positively influencing the region's markets growth. Moreover, regulatory approval from the government authority is also propelling the growth of the market in North America. For instance, in January 2021, the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has approved Seno Medical Instruments Inc., for its Imagio Breast Imaging System. This system is groundbreaking diagnostic breast cancer imaging technology, and it will help physicians better differentiate between benign and malignant breast lesions.

The major companies serving the global women's health diagnostics market include F. Hoffmann-La Roche Lt, General Electric Co., Hologic Inc., Myriad Genetics, Inc., MedGyn Products Inc., and PerkinElmer Inc., Siemens Medical Solutions USA, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Abbott has acquired Walk Vascular, to expand its peripheral vascular offerings. The peripheral thrombectomy systems of Walk Vascular will be integrated into the endovascular products portfolio. Moreover, Walk Vascular JETi Peripheral Thrombectomy System and JETi AIO (All In One) Peripheral Thrombectomy System are systems that are used to remove intravascular clots known as thrombus.

Research Methodology

The market study of the global women's health diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Women's Health Diagnostics Market Research and Analysis by Device

2. Global Women's Health Diagnostics Market Research and Analysis by Test

3. Global Women's Health Diagnostics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodology of the global women's health diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global women's health diagnostics market.
  • Insights about market determinants that are stimulating the global women's health diagnostics market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Women's Health Diagnostics Market
  • Recovery Scenario of Global Women's Health Diagnostics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. F. Hoffmann-La Roche Ltd
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. General Electric Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Hologic, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. PerkinElmer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Siemens Medical Solutions USA, Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Women's Health Diagnostics Market by Type
    • 4.1.1. Diagnostic Devices
    • 4.1.2. Diagnostic Tests
  • 4.2. Global Women's Health Diagnostics Market by Application
    • 4.2.1. Breast Cancer Testing
    • 4.2.2. PAP Smear (PAP) and HPV Test
    • 4.2.3. Infectious Disease Testing
    • 4.2.4. Osteoporosis Testing
    • 4.2.5. Pregnancy and Fertility Testing
    • 4.2.6. Sexually Transmitted Disease Testing
    • 4.2.7. Other
  • 4.3. Global Women's Health Diagnostics Market by End-User
    • 4.3.1. Home Care
    • 4.3.2. Hospitals & Clinics
    • 4.3.3. Diagnostic and Imaging Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

 

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Becton, Dickinson and Co
  • 6.3. BIOMERIEUX, INC.
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. BOSTON IMAGING
  • 6.6. Canon Medical Systems Corp.
  • 6.7. Carestream Health, Inc.
  • 6.8. Cook Group Inc
  • 6.9. DiaSorin S.p.A
  • 6.10. Grifols, S.A.
  • 6.11. Konica Minolta Healthcare Americas, Inc.
  • 6.12. Laboratory Corp.
  • 6.13. Myriad Genetics, Inc.
  • 6.14. MedGyn Products, Inc.
  • 6.15. Ortho Clinical Diagnostics
  • 6.16. Philips International B.V.,
  • 6.17. Quest Diagnostics
  • 6.18. Thermo Fisher Scientific Inc.
  • 6.19. Ziehm Imaging GmbH

LIST OF TABLES

  • 1. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL WOMEN'S HEALTH DIAGNOSTICS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL WOMEN'S HEALTH DIAGNOSTICS TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 5. GLOBAL BREAST CANCER TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL PAP SMEAR (PAP) AND HPV TEST IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

7. GLOBAL PREGNANCY AND FERTILITY TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

8. GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 9. GLOBAL INFECTIOUS DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL OSTEOPOROSIS TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL OTHERS WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 13. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY Dignostic device, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 20. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 22. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 23. EUROPEAN WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST,2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, 2021-2028 (%)
  • 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL WOMEN'S HEALTH DIAGNOSTICS DEVICES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL WOMEN'S HEALTH DIAGNOSTICS TESTSMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 8. GLOBAL BREAST CANCER TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL PAP SMEAR (PAP) AND HPV TEST IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY, 2021 VS 2028 (%)
  • 10. GLOBAL PREGNANCY AND FERTILITY TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL INFECTIOUS DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL OSTEOPOROSIS TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL WOMEN'S OTHER HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 16. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOME CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)